Skipton Building Society Publication of Supplementary Prospectus (0527K)

TIDMFX43

RNS Number : 0527K

Skipton Building Society

16 December 2022

Publication of Supplement dated 16 December 2022 (the "Supplement") to the Prospectus dated 6 June 2022

The following document has been approved by the UK Listing Authority on [16] December 2022 and is available for viewing:

SUPPLEMENT DATED 16 DECEMBER 2022 TO PROSPECTUS DATED 6 JUNE 2022 relating to the Skipton Building Society GBP2,000,000,000 Euro Medium Term Note Programme (the "Prospectus")

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0527K_1-2022-12-16.pdf

A copy of the Supplement and the documents incorporated by reference therein have also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information, please contact:

Jeremy Helme, Head of Capital Markets

Skipton Building Society

The Bailey, Skipton BD23 1DN

Telephone: [phone]

Email: [e-mail]

Website: www.skipton.co.uk

DISCLAIMER - INTENDED ADDRESSEES

References below to the "Prospectus" are to the Prospectus (as defined above) as supplemented by the Supplement.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPBUBDDXGBDGDL

(END) Dow Jones Newswires

December 16, 2022 10:10 ET (15:10 GMT)